Cancer research
Research conducted in one of the largest European trials found that prostate cancer screening can reduce mortality rates by 13%, with the potential to save around 1,500 lives annually in the UK. The study suggests that a targeted approach to screening is necessary, focusing on those at the greatest
Cancer research
Case Comprehensive Cancer Center has initiated a Phase 2 clinical trial, "Study Liquid Nitrogen Spray Cryotherapy Prior To Neoadjuvant Systemic Therapy In Locally Advanced Esophageal Adenocarcinoma," to investigate the effectiveness of Liquid Nitrogen Spray Cryotherapy (LNSC) in addition to chemotherapy versus chemotherapy alone in treating esophageal adenocarcinoma. The
Cancer research
Researchers at Yale University conducted a comprehensive study of colorectal cancer (CRC) screening patterns among privately insured adults in the United States, revealing significant disparities in the use of various screening tests and procedures based on sex, socioeconomic status, and metropolitan versus nonmetropolitan residence. The study, published in the JAMA
Cancer research
A recent study published in Blood Advances has shed light on the potential of a radiotherapy-immunotherapy combination in treating follicular lymphoma and diffuse large B-cell lymphoma. Researchers from the Olivia Newton-John Cancer Research Institute conducted a phase 1 trial, examining the safety and efficacy of escalating radiation doses and durvalumab
Cancer research
A recent study published in Discover Oncology has identified four unfolded protein response (UPR)-related genes that can predict the prognosis of HER2-low breast cancer patients. According to the research conducted by the General Hospital of Ningxia Medical University, the genes COPS5, DKC1, NOP56, and EIF4G1 were significantly associated with
Cancer research
Fresh data on Oncology - Acute Myeloid Leukemia have been presented in a new report. According to research from the University of Texas MD Anderson Cancer Center, Donor-Derived Vg9Vd2 T cells are a promising candidate for treating patients with acute myeloid leukemia (AML) who are unfit for intensive chemotherapy. The
Cancer research
Researchers have published a new study on the limitations of Bevacizumab, a monoclonal antibody used in cancer treatment. In the study, investigators highlighted the drug's failure to increase survival rates in humans, despite its impressive performance in animal models. The research suggested that Bevacizumab's limitations are
Cancer research
Researchers at the University of Michigan and the University of Kansas have developed a revolutionary method to collect and test cancer cells in patients' blood, which could help doctors choose the right breast cancer treatment. This innovative approach aims to identify biomarkers that distinguish patients who would benefit from
Cancer research
Research findings presented in a new report from the Shanxi Province Cancer Hospital in Taiyuan, People's Republic of China, indicate that the combination of serplulimab with platinum-based chemotherapy yields promising results in treating extensive-stage small cell lung cancer (ES-SCLC) liver metastases. The study involved 30 patients with ES-SCLC
Cancer research
Researchers at Bayer HealthCare Pharmaceuticals Inc. have published a study on the long-term responses of patients with metastatic colorectal cancer (mCRC) treated with regorafenib. The study, published in the journal Cancers, analyzed a database of 2444 patients who initiated regorafenib monotherapy between 2013 and 2023. The research found that patients
Cancer research
A groundbreaking study on cancer therapy has revealed a promising approach to augment existing immunotherapies. Researchers at AbbVie Inc. demonstrated that inhibiting TAK1 in tumor cells makes them more susceptible to cytotoxic T cells, thus sensitizing them to TNF-a-induced cytotoxicity. This novel approach leverages the cytotoxic capacity of TNF to
Cancer research
Researchers at Yale University conducted a comprehensive study of colorectal cancer (CRC) screening patterns among privately insured adults in the United States, revealing significant disparities in the use of various screening tests and procedures based on sex, socioeconomic status, and metropolitan versus nonmetropolitan residence. The study, published in the JAMA
